Linda Genen, MD, MPH

Chief Medical Officer at ProgenyHealth
On the record
Represented by:
Share profile 
Bio
Edit

Dr. Linda Genen, Chief Medical Officer (CMO) at ProgenyHealth, oversees medical management and quality operations. ProgenyHealth’s NICU management program works with thousands of NICUs in all fifty states and is a recognized leader in deploying evidence-based neonatal care management services. In recent years, ProgenyHealth has also added additional products to its offering including Payment Validation and Assurance Services as well as a new Maternity Management Program which was launched in 2021. ProgenyHealth remains a market leader in its sector and is the only national, tech-enabled woman’s healthcare company devoted to Maternity and NICU Care Management.

As an experienced physician executive who has focused on maternal child health, Dr. Genen most recently served as a Senior Research Fellow for UnitedHealth Group Research and Development helping to advance research and develop innovations in healthcare. Prior to moving to R&D, she was most recently the Chief Medical Officer for Women’s Health at Optum servicing Fertility, Maternity and NICU programs. Previous roles involved National Medical Director at ParadigmHealth and Alere.

Dr. Genen earned a bachelor’s degree in chemistry and graduated with honors from Wellesley College. She received her Doctor of Medicine from the State University of New York – Downstate Medical Center. She completed her pediatric residency at Columbia Presbyterian Babies and Children’s Hospital and her neonatology fellowship at Yale New Haven Children’s Hospital. Dr. Genen became interested in clinical research and attended the Yale School of Public Health during her fellowship, where she earned a master’s degree in public health focusing on evidenced based medicine. Dr. Genen remains clinically active as a neonatologist at Northwell Cohen Children’s Hospital and is an Assistant Professor of Pediatrics at Hofstra University Medical School.

Recent Quotes
Sign up to view all
  • "The rising risks that dominate the maternal and infant health landscape are tied to an intricate mix of factors: ranging from political and legal shifts to economic pressures to healthcare workforce shortages, systemic bias contributing to mistrust among communities of color, and unhealthy lifestyle habits exacerbated by the pandemic.”

    “Over the last 20 busy years, neonatology has advanced in leaps and bounds. Processes have been standardized and technologies developed: enhanced respiratory support, new monitors for oxygen saturation, phototherapy, brain imaging technique, kangaroo-bonding, advanced nutritional support, the list goes on and on. Innovations, developments, and breakthroughs in our field have entirely improved the outlook for our young born too early. Whereas once, not too long ago, they were unlikely to survive, today’s premature babies are granted a chance to thrive.”

    “In more ways than one, achieving a full continuum of care empowers us to support adherence to guidelines. Regardless of method, we want to achieve quality outcomes that protect our mothers and the most vulnerable among us, our newborns.”

    “By applying a more comprehensive maternity journey, we are able to address social determinants of health that vary by population, geography, and community – and are estimated to impact 80% of an individual’s overall, long-term health. We can tailor outreach by circumstance, and ensure all mothers and newborns have a safety net for care and community.”

    “While the oft-discussed concept of the “patient journey” signals a standardized pathway for all patients, in truth, the experience is fragmented, winding, and too often varied based on demographic or other socioeconomic factors. While individualized care is important, unwanted variations in care can compromise high-quality outcomes. Today, data collection can help organizations pursue an analytical approach to care standardization. Universal data collection can help identify health inequities, gaps in care, and solutions for patient engagement and cost mitigation. Plus, it can shine a light on best practices for care administration and outcome monitoring.”

    “When we begin reaching women earlier and providing more – and more relevant – interactions throughout pregnancy and beyond, our actions will have an impact. Driving towards a comprehensive, community-based care approach that focuses on improving quality outcomes will finally help us move the needle on our maternal and infant health metrics.”

Popularity